Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in MBRX — Moleculin Biotech, Inc.

CIK 1214717 BOSTON, MA
Back to MBRX Full portfolio

Position in MBRX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$131,832
+$57,799 QoQ
Shares Held
47,252
+46.2% QoQ
Ownership
0.243%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 18 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MBRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. MBRX ranks #428 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in MBRX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $131,832 47,252
2026-03-31 $74,033 32,329
2025-12-31 $50,106 15,138
2025-09-30 $110,350 208,210
2025-06-30 $8,313 27,530
2025-03-31 $25,378 26,057
2024-12-31 $37,440 22,024
2024-09-30 $61,962 21,818
2024-06-30 $69,540 19,756
2024-03-31 $98,123 16,603
2023-12-31 $211,642 246,670
2023-09-30 $105,574 246,670
2023-06-30 $142,695 246,451
2023-03-31 $236,592 246,451
2022-12-31 $261,238 246,451
2022-09-30 $261,874 247,051
2022-06-30 $358,223 247,051
2022-03-31 $437,189 245,612
2021-12-31 $456,838 245,612
2021-09-30 $736,836 245,612
2021-06-30 $871,940 237,586
2021-03-31 $713,273 174,822
2020-12-31 $234,726 294,513
2020-09-30 $194,051 238,686
2020-06-30 $220,038 227,313
2020-03-31 $77,163 126,497